The cardiac mapping market industry is projected to grow from USD 2.51 Billion in 2023 to USD 4.954 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.90% during the forecast period (2023 - 2032). The global cardiac mapping market is currently dominated by several market players. The key players are involved in expansion, acquisition, and strategic collaborations to maintain their global footprint. For instance, in February 2020, Rhythm AI agreed to a research collaboration with Biosense Webster Inc. The agreement grants the company access to certain data from the Biosense Webster’s CARTO3 System to support a multi-center clinical trial of its STAR Mapping system.

Key Players

Some of the key players in the Global Cardiac Mapping Market are Abbott Laboratories, GE Healthcare, Boston Scientific Corporation, Medtronic plc., Johnson & Johnson, Koninklijke Philips N.V., Hill-Rom Services, Inc., and others.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is anticipated to hold the largest market share owing to the higher adoption rates of cardiac mapping, available healthcare infrastructure, and the presence of prominent players in this region. The cardiac mapping market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada.

The European cardiac mapping market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The cardiac mapping market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the rising prevalence of cardiovascular diseases and the expansion of healthcare facilities, the market in Asia-Pacific is expected to be the fastest-growing. The cardiac mapping market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

The Global Cardiac Mapping Market has been segmented based on product, indication, and end user.

The market, based on product, has been divided into contact with cardiac mapping systems and non- contact cardiac mapping systems. The contact cardiac mapping systems are likely to hold maximum market share in the global cardiac mapping market owing to its ease of access across the globe.

The cardiac mapping market based on indication has been segregated into atrial fibrillation,

atrial flutter, atrioventricular nodal reentrant tachycardia (AVNRT), Wolff-Parkinson-White Syndrome (WPW), and others. The atrial fibrillation segment is anticipated to hold the largest share in the market due to a large number of patients suffering from the condition.

The end user segments of the cardiac mapping market are hospitals, clinics, diagnostic centers, and others. The hospitals segment is expected to hold the largest share of the market, as these are the primary locations where patients receive diagnosis & treatment.


About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.